Ref (type) | Population | Outcome, Interventions | Results and statistical analysis | Effect size | Favours |
Adverse drug effects | |||||
Systematic review |
705 women 3 RCTs in this analysis |
Withdrawal because of adverse effects
1/566 (1%) with gonadorelin analogues (goserelin or decapeptyl) 11/139 (8%) with danazol |
RR 44.80 95% CI 5.83 to 344.00 |
Large effect size | gonadorelin analogues |
Systematic review |
340 women 3 RCTs in this analysis |
Adverse effects
with gonadorelin analogues (goserelin or decapeptyl) with danazol |